Business Overview: EvoAir Holdings Inc. (OTC: EVOH)

---

Executive Summary

EvoAir Holdings Inc. (formerly Unex Holdings Inc.) is a Nevada corporation that operates through subsidiaries based primarily in Malaysia, Singapore, and China, engaged in the research, manufacturing, trading, and sale of heating, ventilation, and air conditioning (HVAC) products. The company's core product is EvoAir, which it markets as a "first-of-its-kind eco-friendly air-conditioner" designed to reuse waste heat from the outdoor unit, reportedly cutting energy use by at least 20% versus conventional units.

EvoAir is a genuine, if very small, operating manufacturer — not a shell company. It maintains roughly 60,000 square feet of manufacturing space across Malaysia and China and employs about 24 people across its three-country footprint, selling residential and commercial HVAC products, portable air conditioning units, and air-purification products through direct sales, distribution, and OEM licensing arrangements.

---

1. Core Business Model & How They Work

EvoAir earns revenue through direct HVAC product sales, commercial/retrofit installation services, air-purification product sales, and licensing of its patented technology to third-party OEMs.

[ R&D / Patented Heat-Reuse Technology ] ➡️ [ Manufacturing (Malaysia & China, ~60,000 sq ft) ] ➡️ [ Direct Sales / Distribution / Retrofit Installation ] ➡️ [ End Customers (Residential & Commercial) in Malaysia/Singapore/China ] ➡️ [ OEM Licensing of Core Technology (Additional Revenue) ]

Key Operational Drivers

1. Proprietary heat-reuse HVAC technology: The core EvoAir product reuses waste heat from the outdoor condenser unit, a design the company says reduces energy consumption by at least 20% versus standard air conditioners — a genuine technical differentiator if the claim holds up in practice.
2. Commercial and retrofit services: Beyond standard residential units, EvoAir offers commercial air-conditioning units from 5HP to 25HP, retrofitting of existing outdoor condenser units, and customization services — extending its addressable market beyond new-unit sales alone.
3. Air purification product line: EvoAir sells air-sanitizing products (e-Cond Life and QCOV) using an INCU ionic nano copper solution, for which it holds exclusive authorized distributor rights — diversifying revenue beyond pure HVAC.
4. Technology licensing: The company licenses its patented technology to third-party OEM manufacturers, creating a capital-light, higher-margin revenue stream alongside its direct manufacturing business.
5. Health supplement diversification: EvoAir has also launched an INCZN health supplement product, reflecting an opportunistic diversification strategy beyond its core HVAC/air-purification business.

---

2. Product Portfolio

---

3. Competitive Landscape

            ENERGY EFFICIENCY POSITIONING
            Standard efficiency              Eco-friendly/heat-reuse technology
Large  ┌─────────────────────────────┬─────────────────────────────┐
Scale  │ Daikin, Mitsubishi Electric,  │ Large HVAC players'          │
       │ Panasonic (regional HVAC OEMs)│ eco/energy-efficient lines    │
       ├─────────────────────────────┼─────────────────────────────┤
Small  │ Regional/local Malaysia-      │ EVOAIR (patented heat-reuse  │
Scale  │ Singapore-China HVAC brands   │ technology niche)             │
       └─────────────────────────────┴─────────────────────────────┘

Competitive Dynamics

EvoAir's 10-K does not include a standalone competition section; competitive risk is instead discussed primarily through intellectual property risk factors. The company explicitly warns that:

• Competitors could replicate its technology, design around its existing patents, or develop more effective energy-saving alternatives.
• Other parties may hold overlapping or conflicting patents, which could affect EvoAir's own ability to commercialize its products without infringement disputes.

In the broader Southeast Asian/Chinese HVAC market, EvoAir competes against both large multinational HVAC manufacturers (with far greater scale, brand recognition, and R&D budgets) and numerous smaller regional and local HVAC brands, positioning its differentiation specifically around its patented heat-reuse energy-efficiency technology rather than price or brand scale.

---

4. Strategic Strengths & Risks

Strengths

• Patented, differentiated technology: The heat-reuse design underlying EvoAir's core product is a genuine, patent-protected technical differentiator in a market often characterized by commodity competition.
• Diversified revenue streams: Spanning direct HVAC sales, commercial/retrofit services, air purification products, OEM technology licensing, and even a health supplement line reduces dependence on any single product category.
• Real manufacturing footprint: With roughly 60,000 square feet of manufacturing space and ~24 employees across Malaysia and China, EvoAir has tangible operating infrastructure, distinguishing it from a dormant shell company.

Risks

1. Small scale versus multinational HVAC competitors: EvoAir's modest manufacturing footprint and headcount are negligible next to global HVAC manufacturers with vastly greater R&D, brand, and distribution resources.
2. Patent/IP vulnerability: The company itself warns that competitors could design around its patents or that others may hold overlapping patents affecting its own commercialization rights — a genuine legal and competitive risk.
3. Geographic/macroeconomic concentration: Operations and sales are concentrated in Malaysia, Singapore, and China; the company specifically notes that prolonged pandemic effects reduced consumer purchasing power in Malaysia (its primary market), directly pressuring demand.
4. Foreign exchange / repatriation risk: As a holding company dependent on dividends from its operating subsidiaries for cash, EvoAir faces risk from foreign exchange controls or restrictions on repatriating funds from Malaysia/China/Singapore to the U.S. parent.
5. Inflation/input cost exposure: Rising input costs could pressure margins, requiring regular pricing reviews to maintain profitability.
6. OTC market liquidity: As a small OTC-traded company, EvoAir likely has limited institutional visibility, analyst coverage, and share liquidity relative to larger, exchange-listed HVAC competitors.

---

5. Financial Overview

---

6. Summary Conclusion

EvoAir Holdings has built a genuine, if small, HVAC manufacturing and technology-licensing business around its patented heat-reuse air-conditioning design, diversified further into air purification and even a health supplement line. Its real manufacturing footprint across Malaysia and China, combined with a technically differentiated core product, separates it clearly from a dormant shell company. The business's biggest forward risk is scale: operating with roughly 24 employees and a single-digit-million-dollar manufacturing footprint against multinational HVAC competitors with vastly greater resources, while remaining geographically concentrated in Malaysia's consumer market and exposed to the patent-design-around risk the company itself explicitly discloses.